Moreover, the study only evaluated the daytime measurements, and further studies are needed to determine the accuracy of the Aktiia monitor for 24-hour monitoring.īut Aktiia co-founder and CTO Josep Solà believes that while non-invasive, optical heart rate-based sensors may not provide the gold standard yet – we should still accept that they offer ![]() It was conducted on a small sample of patients, and the results may not be generalizable to other populations. However, the study has some obvious limitations. This could be particularly beneficial for patients who require regular blood pressure monitoring, such as those with hypertension, diabetes, or heart disease. And it shows that wrist-worn, non-invasive wearables have a huge role to play in the treatment of hypertension.
0 Comments
Leave a Reply. |